Source:http://linkedlifedata.com/resource/pubmed/id/21546953
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
2011-5-6
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
1546-170X
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
17
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
522
|
| pubmed:meshHeading |
pubmed-meshheading:21546953-Drug Industry,
pubmed-meshheading:21546953-Fabry Disease,
pubmed-meshheading:21546953-Humans,
pubmed-meshheading:21546953-Isoenzymes,
pubmed-meshheading:21546953-National Institutes of Health (U.S.),
pubmed-meshheading:21546953-Orphan Drug Production,
pubmed-meshheading:21546953-Patents as Topic,
pubmed-meshheading:21546953-United States,
pubmed-meshheading:21546953-alpha-Galactosidase
|
| pubmed:year |
2011
|
| pubmed:articleTitle |
NIH faces marching orders on orphan drug shortage.
|
| pubmed:publicationType |
News
|